Serotype distribution of pneumococci isolated from pediatric patients with acute otitis media and invasive infections, and potential coverage of pneumococcal conjugated vaccines;Distribución de serotipos de neumococos aislados de pacientes pediátricos con otitis media aguda e infecciones invasivas y su cobertura potencial a través de vacunas conjugadas

Revista Argentina de Microbiologia

Volumn 45, Issue 1, 2013, Pages 27-33

  Lopardo, Horacio ^a   Reijtman, Vanesa ^a   Fossati, Sofía ^b   Hernández, Claudia ^a   Sommerfleck, Patricia ^a   Bernáldez, Patricia ^a   Litterio, Mirta ^a   Berberian, Griselda ^c   Regueira, Mabel ^a  

^a Servicio de Microbiología ^*  (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Acute otitis media; Invasive infections; Pediatrics; Serotype; Streptococcus pneumoniae; Vaccines

Indexed keywords

PENICILLIN V; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC SENSITIVITY; ARTHRITIS; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CELLULITIS; CHILD; DESCRIPTIVE RESEARCH; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; LUNG CYST; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEWBORN; PERITONITIS; PNEUMOCOCCAL INFECTION; PNEUMONIA; PROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 84876061980     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement, 2011; M100-S21. Wayne, PA, USA
2. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 2009; 15 Suppl 3: 16-20.
3. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5: 83-93.
4. Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008; 197: 1016-10127.
5. Ongkasuwan J, Valdez TA, Hulten KG, Mason EO Jr, Kaplan SL. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics 2008; 122: 34-39.
6. OrganizaciÓn Panamericana de la Salud. Informe regional de SIREVA II, 2009: datos por paÍs y por grupos de edad sobre las caracterÍsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores. OPS, OMS, Washington DC, 2010.
7. Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D provide protection against otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomized double blind efficacy study. Lancet 2006; 367: 740-8
8. th International Symposium on Pneumococci and Pneumococcal Diseases, 2012, Abstract 124, p. 56, Foz d'IguaÇu, Argentina.
9. Sommerfleck P, Berń;ldez P, Reijtman V, Herń;ndez CM, Lopardo H. Otitis media aguda: prevalencia de otopatÓgenos en pacientes de un hospital público. Acta Otorrinolaringol Esp 2012. Disponible en: http//dx.doi. org/10.1016/j.otorri.2012.06.2005.
10. Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L. Immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 2009; 28 (4 Suppl): S66-76.
11. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-46.
12. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002; 2: 25-32.